包装 | 价格(元) |
10 mM * 1 mL in DMSO | 电议 |
5mg | 电议 |
10mg | 电议 |
25mg | 电议 |
50mg | 电议 |
100mg | 电议 |
200mg | 电议 |
500mg | 电议 |
生物活性 | GB-110 hydrochloride is a potent, orally active, and nonpeptidicprotease activated receptor2 (PAR2)agonist. GB-110 hydrochloride selectively induces PAR2-mediated intracellular Ca2+release in HT29 cells with anEC50of 0.28 μM[1]. | ||||||||||||||||
IC50& Target | Protease activated receptor 2[1] | ||||||||||||||||
体外研究 (In Vitro) | In an intracellular Ca2+(iCa2+) mobilization assay using HT29 colon cancer cells, GB110 (EC50240±20 nM; pEC506.7±0.05) is equipotent with the peptide agonist 2f-LIGRLO-NH2 (EC50210±30 nM; pEC506.6±0.05), 10-fold more potent than SLIGRL-NH2, but ~35-fold less potent than trypsin (EC506±0.5 nM; pEC508.2±0.8)[2]. | ||||||||||||||||
分子量 | 645.23 | ||||||||||||||||
性状 | Solid | ||||||||||||||||
Formula | C33H49ClN6O5 | ||||||||||||||||
运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||||||||||
储存方式 | 4°C, sealed storage, away from moisture *In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture) | ||||||||||||||||
溶解性数据 | In Vitro: DMSO : 125 mg/mL(193.73 mM;Need ultrasonic) 配制储备液
* 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 In Vivo: 请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照In Vitro方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用;
以下溶剂前显示的百
|